T1	Participants 359 495	999 trial participants for whom follow-up data were available, 135 delivered by Caesarean section (CS), and 864 had a vaginal birth (VB)
T2	Participants 317 351	3 Montreal hospitals in 1990-1991.
T3	Participants 600 679	3 months postpartum in women who had a VB with the rates in women who had a CS.
